The Cuban vaccine against the Abdala coronavirus has shown up to 100% effectiveness against severe disease and a decrease in mortality. Writes about this on July 16 Prensa Latina with reference to the developers.
It is noted that the drug of the Cuban Center for Genetic Engineering and Biotechnology CIGB showed good results during the third phase of trials.
So, the vaccine prevented the symptoms of COVID-19 in 92.28% of cases.
“There is already clinical efficacy data from the Abdala Phase III study with excellent results and is now scaled up to an efficacy study involving more than 300,000 people,” said Development Center Director Martha Ayala.
In total, Cuban scientists have developed four vaccines against the coronavirus. In addition to the Finley Vaccine Institute’s two developments (Soberana 01 and Soberana 02), two drugs (intranasal Mambisa and injectable Abdala) are being investigated by CIGB Soberana 02 and Abdala are already in production.
On July 14, the head of the Russian Ministry of Health, Mikhail Murashko, said that coronavirus vaccines effectively protect against severe complications of the disease. At the same time, he noted that there is still no substantiated data on what level of antibodies is sufficient to protect the body from COVID-19.
On July 11, the virologist, Doctor of Medical Sciences Anatoly Altstein reminded the Russians that vaccination and its pace are important for the fight against coronavirus infection.
Large-scale vaccination against COVID-19 has been taking place in Russia since January 18. The vaccination is given free of charge to everyone. At the moment, four drugs for coronavirus are registered in the country: Sputnik V, Sputnik Light, EpiVacCorona and KoviVak.